| 2024 | 2023 | 2022 | 2021 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 148,5 k € | +665.6% | 19,4 k € | -82.6% | 111,8 k € | +75.5% | 63,7 k € | +4.2% | 61,1 k € | -35.8% | 95,2 k € | -36.4% | 149,6 k € | +1.9% | 146,8 k € | -4.4% | 153,5 k € | -17.6% | 186,4 k € | -2.8% | 191,7 k € | +25.6% | 152,6 k € | -32.8% | 227,2 k € | +1.4% | 224,1 k € | |
| EBITDA | 77,3 k € | +222.4% | -63,2 k € | -340.1% | 26,3 k € | +959.9% | -3,1 k € | -146.4% | 6,6 k € | -80.6% | 33,9 k € | -61.7% | 88,5 k € | +4.9% | 84,3 k € | -7.8% | 91,5 k € | -29.2% | 129,3 k € | +9.1% | 118,5 k € | +29.9% | 91,2 k € | -39.9% | 151,8 k € | -2.3% | 155,4 k € | |
| Operating profit | 77,3 k € | +221.0% | -63,9 k € | -343.0% | 26,3 k € | +709.6% | -4,3 k € | -134.7% | -1,8 k € | -189.3% | 2,1 k € | -95.3% | 43,4 k € | +14.9% | 37,8 k € | -17.0% | 45,5 k € | +49.7% | 30,4 k € | -62.6% | 81,3 k € | +37.9% | 59,0 k € | -40.0% | 98,2 k € | -15.7% | 116,6 k € | |
| Profit/loss | 62,2 k € | +143.9% | -141,8 k € | -2190.2% | 6,8 k € | +157.2% | -11,9 k € | +39.0% | -19,4 k € | -12.2% | -17,3 k € | -1425.2% | 1,3 k € | -69.3% | 4,3 k € | -56.8% | 9,9 k € | -11.9% | 11,2 k € | -83.3% | 66,9 k € | +35.0% | 49,6 k € | -43.9% | 88,4 k € | -14.8% | 103,8 k € | |
| Equity | 86,1 k € | +260.4% | 23,9 k € | -85.6% | 165,7 k € | +4.3% | 158,9 k € | -53.0% | 338,4 k € | -5.4% | 357,8 k € | -4.6% | 375,1 k € | +0.3% | 373,8 k € | +1.2% | 369,6 k € | +2.7% | 359,7 k € | +3.2% | 348,5 k € | +23.8% | 281,6 k € | +21.4% | 232,0 k € | +61.5% | 143,6 k € | |
| Total assets | 392,7 k € | +32.7% | 296,0 k € | -38.6% | 482,0 k € | +5.3% | 457,6 k € | -25.6% | 614,9 k € | +5.3% | 584,0 k € | +4.1% | 561,0 k € | -5.7% | 595,1 k € | -7.6% | 644,4 k € | +14.0% | 565,1 k € | +15.4% | 489,8 k € | +34.0% | 365,5 k € | +8.1% | 338,3 k € | +0.9% | 335,4 k € | |
| Cash | 87,8 k € | +2248.9% | 3,7 k € | -83.9% | 23,3 k € | -39.7% | 38,6 k € | -61.4% | 99,9 k € | +9.5% | 91,2 k € | -9.1% | 100,4 k € | -4.5% | 105,1 k € | +53.7% | 68,4 k € | +119.1% | 31,2 k € | +138486.2% | 22,5 € | -87.3% | 177,7 € | -98.3% | 10,2 k € | +81.5% | 5,6 k € | |
| Debts | 305,9 k € | +12.4% | 272,1 k € | -14.0% | 316,4 k € | +5.9% | 298,8 k € | +8.0% | 276,5 k € | +22.2% | 226,2 k € | +22.0% | 185,5 k € | -15.1% | 218,5 k € | -20.2% | 273,7 k € | +33.3% | 205,4 k € | +45.4% | 141,2 k € | +68.3% | 83,9 k € | -21.0% | 106,3 k € | -44.6% | 191,8 k € | |
| Staff | — | 0 | — | — | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1,2 | 2 | 1,4 | ||||||||||||||
Public limited company · Schelle · incorporated on 15/09/1998
Public limited company profitable and well capitalised. Cash position rising (+2248.9%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
NEIRYNCK en VOGT is a Public limited company incorporated in 1998. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Schelle.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette